JPH0226672B2 - - Google Patents
Info
- Publication number
- JPH0226672B2 JPH0226672B2 JP29560985A JP29560985A JPH0226672B2 JP H0226672 B2 JPH0226672 B2 JP H0226672B2 JP 29560985 A JP29560985 A JP 29560985A JP 29560985 A JP29560985 A JP 29560985A JP H0226672 B2 JPH0226672 B2 JP H0226672B2
- Authority
- JP
- Japan
- Prior art keywords
- methylaminoethanol
- hydroxyethyl
- compound
- salt
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 isostearyl Chemical group 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 18
- 239000003599 detergent Substances 0.000 claims description 14
- 238000004140 cleaning Methods 0.000 claims description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 11
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 claims description 4
- 230000000774 hypoallergenic effect Effects 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- YGGXZTQSGNFKPJ-UHFFFAOYSA-N methyl 2-naphthalen-1-ylacetate Chemical compound C1=CC=C2C(CC(=O)OC)=CC=CC2=C1 YGGXZTQSGNFKPJ-UHFFFAOYSA-N 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 238000004925 denaturation Methods 0.000 description 12
- 230000036425 denaturation Effects 0.000 description 12
- 238000005187 foaming Methods 0.000 description 12
- 239000004094 surface-active agent Substances 0.000 description 10
- 108010058846 Ovalbumin Proteins 0.000 description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 7
- 229940092253 ovalbumin Drugs 0.000 description 7
- 239000002453 shampoo Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000010998 test method Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Chemical class 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- MMLXLDDTSRFVKB-UHFFFAOYSA-N 1-(methylamino)ethyl dihydrogen phosphate Chemical compound CNC(C)OP(O)(O)=O MMLXLDDTSRFVKB-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- MIOJOMDSWUFZBZ-UHFFFAOYSA-N 2-(2-oxoheptylamino)ethanesulfonic acid Chemical class CCCCCC(=O)CNCCS(O)(=O)=O MIOJOMDSWUFZBZ-UHFFFAOYSA-N 0.000 description 1
- URACZAGMGOMSLF-UHFFFAOYSA-N 2-(2-oxononadecylamino)ethanesulfonic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)CNCCS(O)(=O)=O URACZAGMGOMSLF-UHFFFAOYSA-N 0.000 description 1
- SLQVHWZLWVVHBD-UHFFFAOYSA-N 2-(2-oxotridecylamino)ethanesulfonic acid Chemical class CCCCCCCCCCCC(=O)CNCCS(O)(=O)=O SLQVHWZLWVVHBD-UHFFFAOYSA-N 0.000 description 1
- CMJUNAQINNWKAU-KTKRTIGZSA-N 2-[[(z)-2-oxononadec-10-enyl]amino]ethanesulfonic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)CNCCS(O)(=O)=O CMJUNAQINNWKAU-KTKRTIGZSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- REAYFGLASQTHKB-UHFFFAOYSA-N [2-[3-(1H-pyrazol-4-yl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound N1N=CC(=C1)C=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 REAYFGLASQTHKB-UHFFFAOYSA-N 0.000 description 1
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Description
(産業上の利用分野)
本発明は、起泡性、洗浄性等の洗浄剤としての
必須要件を満足しながら、皮膚に対する刺激性が
著しく低い洗浄剤組成物に関するものである。
(従来の技術)
従来、蛋白質変性力の強い界面活性剤や界面活
性剤組成物では、これらを連用することにより強
度の手荒れ現象が認められるのに対し、蛋白質変
性力の小さい界面活性剤やその組成物(例えばシ
ヤンプー)は、長期間連用しても手荒れ等の皮膚
障害が起こり難く、皮膚に対する刺激性が著しく
低いことがよく知られている。
一方、後記の一般式(A)で表わされる高級脂肪酸
アミドスルホン酸塩は、洗浄力に優れていること
から洗顔料やシヤンプー等の洗浄剤に配合使用さ
れているが、蛋白質変性力や皮膚刺激性が強く手
荒れ等の皮膚障害を起こしやすい欠点がある。こ
のような背景と生活水準の高度化に伴い、人体に
対して高度な安全性を有する低皮膚刺激性の界面
活性剤や洗浄剤組成物の開発が強く要望されるよ
うになつて来ているのが現状である。
(発明が解決しようとする問題点)
本発明者等は、前記従来技術の難点を改良せん
として鋭意研究した結果、先に出願した(特願昭
59−216532号、特願昭60−213155号)、界面活性
剤の後記一般式(B)で表わされるN―(2―アルキ
ル―2―ヒドロキシエチル)―N―メチルアミノ
エタノールリン酸エステル塩の適当量を、後記一
般式(A)で表わされる高級脂肪酸アミドスルホン酸
塩に混合する場合は、起泡性、洗浄性等の洗浄剤
としての必須要件を満足しながら、蛋白質変性力
が小さく、手荒れ等の皮膚障害を起し難く皮膚刺
激性の著しく低い洗浄剤組成物が得られることを
見出し、本発明を完成するに至つた。
本発明の目的は、起泡性、洗浄性等の洗浄剤と
しての必須要件を満足しながら、皮膚に対する刺
激性が著しく低い洗浄剤組成物を提供することに
ある。
(問題点を解決するための手段)
上述の目的は、
一般式(A)
(上記式中でR1はカプリル基、ラウリル基、ミ
リスチル基、パルミチル基、ステアリル基、イソ
ステアリル基またはオレイル基、M1はナトリウ
ム、カリウム、アンモニウムまたはトリエタノー
ルアンモニウムである。)
で表わされる高級脂肪酸アミドスルホン酸塩と、
一般式(B)
(上記式中で、R2はカプリル基、ラウリル基、
ミリスチル基、パルミチル基、ステアリル基また
はオレイル基、M2はナトリウム、カリウム、ア
ンモニウムまたはトリエタノールアンモニウムで
ある。)
で表わされるN―(2―アルキル―2―ヒドロキ
シエチル)―N―メチルアミノエタノールリン酸
エステル塩とを有効成分として含有している低刺
激性洗浄剤組成物によつて達成される。
本発明における前記一般式(A)で表わされる高級
脂肪酸アミドスルホン酸塩としては、例えばカプ
ロイルメチルタウリン、ラウロイルメチルタウリ
ン、ミリストイルメチルタウリン、パルミトイル
メチルタウリン、ステアロイルメチルタウリンお
よびオレオイルメチルタウリンのナトリウム塩、
カリウムム塩、アンモニウム塩、トリエタノール
アミン塩等が挙げられる。
また前記一般式(B)で表わされるN―(2―アル
キル―2―ヒドロキシエチル)―N―メチルアミ
ノエタノールリン酸エステル塩としては、例え
ば、N―(2―ラウリル―2―ヒドロキシエチ
ル)―N―メチルアミノエタノールリン酸エステ
ル1ナトリウム塩(以下、化合物1という)、N
―(2―ラウリル―2―ヒドロキシエチル)―N
―メチルアミノエタノールリン酸エステル1カリ
ウム塩(化合物2)、N―(2―ラウリル―2―
ヒドロキシエチル)―N―メチルアミノエタノー
ルリン酸エステル1アンモニウム塩(化合物3)、
N―(2―ラウリル―2―ヒドロキシエチル)―
N―メチルアミノエタノールリン酸エステル1ト
リエタノールアミン塩(化合物4)、N―(2―
カプリル―2―ヒドロキシエチル)―N―メチル
アミノエタノールリン酸エステル1ナトリウム塩
(化合物5)、N―(2―カプリル―2―ヒドロキ
シエチル)―N―メチルアミノエタノールリン酸
エステル1カリウム塩(化合物6)、N―(2―
カプリル―2―ヒドロキシエチル)―N―メチル
アミノエタノールリン酸エステル1アンモニウム
塩(化合物7)、N―(2―カプリル―2―ヒド
ロキシエチル)―N―メチルアミノエタノールリ
ン酸エステル1トリエタノールアミン塩(化合物
8)、N―(2―ミリスチル―2―ヒドロキシエ
チル)―N―メチルアミノエタノールリン酸エス
テル1ナトリウム塩(化合物9)、N―(2―ミ
リスチル―2―ヒドロキシエチル)―N―メチル
アミノエタノールリン酸エステル1カリウム塩
(化合物10)、N―(2―ミリスチル―2―ヒドロ
キシエチル)―N―メチルアミノエタノールリン
酸エステル1アンモニウム塩(化合物11)、N―
(2―ミリスチル―2―ヒドロキシエチル)―N
―メチルアミノエタノールリン酸エステル1トリ
エタノールアミン塩(化合物12)、N―(2―パ
ルミチル―2―ヒドロキシエチル)―N―メチル
アミノエタノールリン酸エステル1ナトリウム塩
(化合物13)、N―(2―パルミチル―2―ヒドロ
キシエチル)―N―メチルアミノエタノールリン
酸エステル1カリウム塩(化合物14)、N―(2
―パルミチル―2―ヒドロキシエチル)―N―メ
チルアミノエタノールリン酸エステル1アンモニ
ウム塩(化合物15)、N―(2―パルミチル―2
―ヒドロキシエチル)―N―メチルアミノエタノ
ールリン酸エステル1トリエタノールアミン塩
(化合物16)、N―(2―ステアリル―2―ヒドロ
キシエチル)―N―メチルアミノエタノールリン
酸エステル1ナトリウム塩(化合物17)、N―
(2―ステアリル―2―ヒドロキシエチル)―N
―メチルアミノエタノールリン酸エステル1カリ
ウム塩(化合物18)、N―(2―ステアリル―2
―ヒドロキシエチル)―N―メチルアミノエタノ
ールリン酸エステル1アンモニウム塩(化合物
19)、(2―ステアリル―2―ヒドロキシエチル)
―N―メチルアミノエタノールリン酸エステル1
トリエタノールアミン塩(化合物20)、N―(2
―オレイル―2―ヒドロキシエチル)―N―メチ
ルアミノエタノールリン酸エステル1ナトリウム
塩(化合物21)、N―(2―オレイル―2―ヒド
ロキシエチル)―N―メチルアミノエタノールリ
ン酸エステル1カリウム塩(化合物22)、N―
(2―オレイル―2―ヒドロキシエチル)―N―
メチルアミノエタノールリン酸エステル1アンモ
ニウム塩、(化合物23)及びN―(2―オレイル
―2―ヒドロキシエチル)―N―メチルアミノエ
タノールリン酸エステル1トリエタノールアミン
塩(化合物24)等である。
前記一般式(A)で表わされる高級脂肪酸アミドス
ルホン酸塩は、充分なる起泡性、洗浄性等の界面
活性能は有するものの、蛋白質変性力は強く、単
独で用いた場合には所望の低刺激性洗浄剤は得ら
れない。
一方、前記一般式(B)で表わされるN―(2―ア
ルキル―2―ヒドロキシエチル)―N―メチルア
ミノエタノールリン酸エステル塩は蛋白質変性力
は非常に低く、刺激性は弱いものであり、かつ起
泡性、洗浄性等の界面活性能は良好である。
本発明者等は、前記一般式(A)で表わされる高級
脂肪酸アミドスルホン酸塩と、前記一般式(B)で表
わされるN―(2―アルキル―2―ヒドロキシエ
チル)―N―メチルアミノエタノールリン酸エス
テル塩とを、ある一定の比率で混合した場合、お
のおの単独の場合より粘度上昇、臨界ミセル濃度
の低下等の現象がおこる事を発見し、高級脂肪酸
アミドスルホン酸塩とN―(2―アルキル―2―
ヒドロキシエチル)―N―メチルアミノエタノー
ルリン酸エステル塩との複合体が形成されたもの
と推定したが、この一定比率の混合物では、起泡
性、洗浄性等の界面活性能は高級脂肪酸アミドス
ルホン酸塩単独の場合に優るとも劣らず、同時に
蛋白質変性力はN―(2―アルキル―2―ヒドロ
キシエチル)―N―メチルアミノエタノールリン
酸エステル塩単独の場合とほぼ同等の程度まで著
しく低下することを発見したものである。
即ち、混合して複合体を形成することにより、
明らかに相乗効果が発揮され、優れた界面活性能
を維持しつつ、蛋白質変性能の低い低刺激性洗浄
剤組成物を得ることに成功したものである。
この(A):(B)の混合比(重量比)は、3:1乃至
1:20の範囲が望ましい。この範囲以外の混合比
や、他のアニオン界面活性剤等を多量に加えて系
のバランスを崩した場合では、充分な蛋白質変性
能の低下効果が得られない。
また(A)+(B)の含有量は、洗浄剤組成物全量中の
10乃至50重量%が好ましい。
本発明の洗浄剤組成物は、所望により、洗浄剤
に一般に配合される成分、例えば、高級アルコー
ル、ラノリン誘導体、蛋白誘導体や、ポリエチレ
ングリコールの脂肪酸エステル類等の油性成分、
プロピレングリコール、グリセリン、ポリエチレ
ングリコール等の保湿剤成分、脂肪酸アルカロー
ルアマイド、ポリオキシエチレンアルキルエーテ
ル及びアルキルアミンオキシド等の非イオン界面
活性剤、水溶性高分子物質(アニオン性、非イオ
ン性、カチオン性のものを含む)、金属イオン封
鎖剤、防腐剤、殺菌剤、PH調整剤、紫外線吸収
剤、酸化防止剤、色素及び香料等を含むことがで
きる。
(実施例)
次に本発明を実施例をもつて詳細に説明する
が、本発明はこれにより限定されるものではな
い。実施例に先立ち、各実施例で採用した試験
法、評価法を説明する。
起泡性試験法
ロスマイルズ試験法(ASTMD 1173―53)に
よつて行つた。また、評価の基準を次のように設
定した。
〇…泡立ち良好 泡量 200ml以上
△…泡立ち普通 泡量 150ml以上 200ml未満
×…泡立ち不良 泡量 150ml未満
洗浄性試験法
5cm×5cmのウールモスリン布にラノリン7%
及びスダン0.005%のクロロホルム溶液0.4mlを
均一に塗布し乾燥させ、この汚染布を3%の洗浄
剤溶液40mlが入つた約100mlのガラス製シリンダ
ー中に入れ、40℃の恒温槽中で15分振とうし、汚
洗布を流水中でよくすすぎ、乾燥させ、反射率を
調べ、次式により洗浄率を求めた。
洗浄率=洗浄後の反射率−洗浄前の反射率/原布の反射
率−洗浄前の反射率
また、評価の基準を次のように設定した。
〇:洗浄性良好 洗浄効率 80%以上
△:洗浄性普通 洗浄効率 60%以上 80%未満
×:洗浄性不良 洗浄効率 60%未満
蛋白質変性率測定法
水系高速液体クロマトグラフイーを利用し、卵
白アルブミンPH7緩衝溶液に、試験濃度1%にな
るように試料を加えた場合の卵白アルブミン変性
率を、220nmの吸収ピークを用いて測定した。
変性率(%)=Ho−Hs/Ho×100
Ho:卵白アルブミンの220nm吸収ピークの高
さ
Hs:卵白アルブミン緩衝溶液に試料を加えた
時の220nm吸収ピークの高さ
評価の基準を次のように設定した。
◎:卵白アルブミン変性率 30%未満
〇:卵白アルブミン変性率 30%以上 60%未満
△:卵白アルブミン変性率 60%以上 80%未満
×:卵白アルブミン変性率 80%以上
手荒れ試験法
各試料につき、男女各5名、合計10名のパネル
を用い、左右どちらか一方の手を、試料濃度5
%、温度35℃の水溶液に、他方の手を同温度の水
に10分間浸漬する操作を1日当り2回、2日間続
けて行ない、左右の手の肌荒れ状態の差を肉眼で
判定した。
◎…手荒れ性著しく弱い 10人中0〜1名
試料側に手荒れが認められた
〇…手荒れ性やや弱い 10人中2〜4名
試料側に手荒れが認められた
△…手荒れ性やや強い 10人中5〜7名
試料側に手荒れが認められた
×…手荒れ性著しく強い 10人中8〜10名
試料側に手荒れが認められた
実施例1〜8、比較例1〜7
実施例1〜8及び比較例1〜7では、第1表及
び第2表に記載の配合組成よりなるシヤンプーを
調製し、その起泡性、洗浄性、蛋白質変性率及び
手荒れ性を調べた結果を、第1表及び第2表に示
す。
(Field of Industrial Application) The present invention relates to a detergent composition that satisfies the essential requirements for a detergent, such as foaming properties and cleansing properties, and has extremely low irritation to the skin. (Prior art) Conventionally, with surfactants and surfactant compositions that have a strong protein denaturing power, severe roughness has been observed when used repeatedly, whereas surfactants and surfactant compositions that have a low protein denaturing power have been used for a long time. It is well known that the composition (for example, shampoo) hardly causes skin disorders such as rough hands even when used for a long period of time, and has extremely low irritation to the skin. On the other hand, higher fatty acid amide sulfonate represented by the general formula (A) below is used in cleansing agents such as facial cleansers and shampoos due to its excellent cleaning power, but it also has protein denaturing power and skin irritation. It has the disadvantage of being highly sensitive and prone to skin problems such as rough hands. Against this background and with the advancement of living standards, there is a strong demand for the development of low skin irritation surfactants and detergent compositions that are highly safe for the human body. is the current situation. (Problems to be Solved by the Invention) As a result of intensive research aimed at improving the drawbacks of the above-mentioned prior art, the present inventors have previously filed an application (Patent Application No.
No. 59-216532, Japanese Patent Application No. 60-213155), surfactant N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester salt represented by general formula (B) below. When an appropriate amount is mixed with the higher fatty acid amide sulfonate represented by the general formula (A) below, it satisfies the essential requirements as a detergent such as foaming properties and detergency, while having a low protein denaturing power. The present inventors have discovered that it is possible to obtain a detergent composition that hardly causes skin disorders such as rough hands and has extremely low skin irritation, and has completed the present invention. An object of the present invention is to provide a detergent composition that satisfies essential requirements for a detergent such as foaming properties and cleansing properties, and has extremely low irritation to the skin. (Means for solving the problem) The above purpose is as follows: General formula (A) (In the above formula, R 1 is a caprylic, lauryl, myristyl, palmityl, stearyl, isostearyl, or oleyl group, and M 1 is sodium, potassium, ammonium, or triethanolammonium.) Fatty acid amide sulfonate and general formula (B) (In the above formula, R 2 is a caprylic group, a lauryl group,
myristyl, palmityl, stearyl or oleyl group, M2 is sodium, potassium, ammonium or triethanolammonium. This is achieved by a mild detergent composition containing N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate salt represented by the following formula as an active ingredient. Examples of the higher fatty acid amide sulfonate represented by the general formula (A) in the present invention include sodium salts of caproylmethyltaurine, lauroylmethyltaurine, myristoylmethyltaurine, palmitoylmethyltaurine, stearoylmethyltaurine, and oleoylmethyltaurine. ,
Examples include potassium salts, ammonium salts, triethanolamine salts, and the like. Further, as the N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate salt represented by the general formula (B), for example, N-(2-lauryl-2-hydroxyethyl)- N-methylaminoethanol phosphate monosodium salt (hereinafter referred to as compound 1), N
-(2-lauryl-2-hydroxyethyl)-N
-Methylaminoethanol phosphate monopotassium salt (compound 2), N-(2-lauryl-2-
hydroxyethyl)-N-methylaminoethanol phosphate ester monoammonium salt (compound 3),
N-(2-lauryl-2-hydroxyethyl)-
N-methylaminoethanol phosphate ester 1 triethanolamine salt (compound 4), N-(2-
Capryl-2-hydroxyethyl)-N-methylaminoethanol phosphate monosodium salt (Compound 5), N-(2-capryl-2-hydroxyethyl)-N-methylaminoethanol phosphate monopotassium salt (Compound 5) 6), N-(2-
Capryl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester 1 ammonium salt (compound 7), N-(2-capryl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester 1 triethanolamine salt (Compound 8), N-(2-Myristyl-2-hydroxyethyl)-N-methylaminoethanol phosphate monosodium salt (Compound 9), N-(2-Myristyl-2-hydroxyethyl)-N-methyl Aminoethanol phosphate monopotassium salt (Compound 10), N-(2-myristyl-2-hydroxyethyl)-N-methylaminoethanol phosphate monoammonium salt (Compound 11), N-
(2-myristyl-2-hydroxyethyl)-N
-Methylaminoethanol phosphate ester 1 triethanolamine salt (compound 12), N-(2-palmityl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester 1 sodium salt (compound 13), N-(2 -palmityl-2-hydroxyethyl)-N-methylaminoethanol phosphate monopotassium salt (compound 14), N-(2
-palmityl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester 1 ammonium salt (compound 15), N-(2-palmityl-2
-Hydroxyethyl)-N-methylaminoethanol phosphate ester 1 triethanolamine salt (Compound 16), N-(2-stearyl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester 1 sodium salt (Compound 17) ), N-
(2-stearyl-2-hydroxyethyl)-N
-Methylaminoethanol phosphate monopotassium salt (compound 18), N-(2-stearyl-2
-Hydroxyethyl)-N-methylaminoethanol phosphate monoammonium salt (compound
19), (2-stearyl-2-hydroxyethyl)
-N-methylaminoethanol phosphate 1
Triethanolamine salt (compound 20), N-(2
-oleyl-2-hydroxyethyl)-N-methylaminoethanol phosphate monosodium salt (compound 21), N-(2-oleyl-2-hydroxyethyl)-N-methylaminoethanol phosphate monopotassium salt ( Compound 22), N-
(2-oleyl-2-hydroxyethyl)-N-
These include methylaminoethanol phosphate 1 ammonium salt (Compound 23) and N-(2-oleyl-2-hydroxyethyl)-N-methylaminoethanol phosphate 1 triethanolamine salt (Compound 24). Although the higher fatty acid amide sulfonate represented by the general formula (A) has sufficient surfactant properties such as foaming properties and detergent properties, it has a strong protein denaturing power and cannot reach the desired low level when used alone. No irritating cleaning agents are obtained. On the other hand, the N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate salt represented by the general formula (B) has very low protein denaturing power and weak irritation. In addition, it has good surfactant properties such as foaming properties and detergency. The present inventors have developed a higher fatty acid amide sulfonate represented by the general formula (A) and N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol represented by the general formula (B). It was discovered that when phosphoric acid ester salts are mixed at a certain ratio, phenomena such as increased viscosity and decreased critical micelle concentration occur compared to the case of each alone. -Alkyl-2-
It was presumed that a complex was formed with N-methylaminoethanol (hydroxyethyl)-N-methylaminoethanol phosphoric acid ester salt, but in this mixture at a certain ratio, surfactant properties such as foaming and detergent properties were lower than that of higher fatty acid amide sulfone. It is not inferior to the case of the acid salt alone, and at the same time, the protein denaturation power is significantly reduced to almost the same level as the case of the N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester salt alone. This is what I discovered. That is, by mixing to form a complex,
This clearly shows a synergistic effect, and we succeeded in obtaining a hypoallergenic detergent composition that maintains excellent surfactant ability and has low protein denaturation ability. The mixing ratio (weight ratio) of (A):(B) is preferably in the range of 3:1 to 1:20. If the mixing ratio is outside this range or if a large amount of other anionic surfactant is added to disrupt the balance of the system, a sufficient effect of lowering protein denaturation performance cannot be obtained. In addition, the content of (A) + (B) in the total amount of the cleaning composition is
10 to 50% by weight is preferred. The cleaning composition of the present invention may optionally contain components commonly added to cleaning agents, such as higher alcohols, lanolin derivatives, protein derivatives, and oily components such as fatty acid esters of polyethylene glycol.
Humectant ingredients such as propylene glycol, glycerin, and polyethylene glycol, nonionic surfactants such as fatty acid alkolamide, polyoxyethylene alkyl ether, and alkyl amine oxide, and water-soluble polymeric substances (anionic, nonionic, and cationic) ), sequestering agents, preservatives, bactericidal agents, PH regulators, ultraviolet absorbers, antioxidants, pigments, fragrances, etc. (Example) Next, the present invention will be explained in detail with reference to Examples, but the present invention is not limited thereto. Prior to the examples, the test methods and evaluation methods employed in each example will be explained. Foaming test method: Tested according to the Ross Miles test method (ASTMD 1173-53). In addition, the evaluation criteria were set as follows. 〇…Good lathering Foam volume 200ml or more △…Normal foaming Foam volume 150ml or more Less than 200ml×…Poor foaming Foam volume less than 150ml Cleaning test method Lanolin 7% on a 5cm x 5cm wool muslin cloth
0.4 ml of a 0.005% chloroform solution of Sudan and Sudan was evenly applied and dried, and the contaminated cloth was placed in a glass cylinder of approximately 100 ml containing 40 ml of a 3% detergent solution, and placed in a constant temperature bath at 40°C for 15 minutes. After shaking, the dirty washing cloth was thoroughly rinsed under running water, dried, and the reflectance was examined, and the cleaning rate was determined by the following formula. Cleaning rate=Reflectance after cleaning−Reflectance before cleaning/Reflectance of original fabric−Reflectance before cleaning In addition, evaluation criteria were set as follows. 〇: Good cleaning performance Cleaning efficiency 80% or more △: Average cleaning performance Washing efficiency 60% or more Less than 80% The ovalbumin denaturation rate when a sample was added to a PH7 buffer solution at a test concentration of 1% was measured using an absorption peak at 220 nm. Denaturation rate (%) = Ho−Hs/Ho×100 Ho: Height of the 220nm absorption peak of ovalbumin Hs: Height of the 220nm absorption peak when the sample is added to the ovalbumin buffer solution The evaluation criteria are as follows: It was set to ◎: Ovalbumin denaturation rate less than 30% 〇: Ovalbumin denaturation rate 30% or more but less than 60% △: Ovalbumin denaturation rate 60% or more but less than 80% ×: Ovalbumin denaturation rate 80% or more Rough hand test method For each sample, male and female Using a panel of 5 people each, 10 people in total, with one hand on either the left or right hand, sample concentration 5
%, and the other hand was immersed in water at the same temperature for 10 minutes in an aqueous solution at a temperature of 35°C, twice a day for two consecutive days, and the difference in rough skin between the left and right hands was visually determined. ◎... Extremely weak hand roughness 0 to 1 out of 10 people Rough hands were observed on the sample side 〇... Hand roughness was slightly weak 2 to 4 out of 10 people Rough hands were observed on the sample side △... Hand roughness was slightly strong 10 people 5 to 7 middle school participants Rough hands were observed on the sample side ×... Extremely rough hands 8 to 10 out of 10 Rough hands were observed on the sample side Examples 1 to 8, Comparative Examples 1 to 7 Examples 1 to 8 In Comparative Examples 1 to 7, shampoos having the compositions listed in Tables 1 and 2 were prepared, and their foaming properties, detergency, protein denaturation rate, and roughness on hands were investigated. and shown in Table 2.
【表】【table】
【表】【table】
【表】
実施例 9
次の配合組成よりなるボデイシヤンプーを調製
した。
ミリスチルメチルタウリン―K 8%(重量)
化合物 1 6
化合物 5 6
グリセリン 2
香 料 0.3
水 残余
このボデイシヤンプーの起泡性、洗浄性、蛋白
質変性率、手荒れ性を調べた結果、各々〇、〇、
◎、◎であつた。
実施例 10
次の配合組成よりなるシヤンプーを調製した。
ココイルメチルタウリン―Na 4
化合物 4 8
化合物 8 8
ヤシ脂肪酸ジエタノールアマイド 5
香 料 0.3
水 残余
このシヤンプーの起泡性、洗浄性、蛋白質変性
率、手荒れ性を調べた結果、各々〇、〇、◎、◎
であつた。[Table] Example 9 A body shampoo having the following composition was prepared. Myristylmethyltaurine-K 8% (weight) Compound 1 6 Compound 5 6 Glycerin 2 Fragrance 0.3 Water Residual As a result of investigating the foaming properties, cleansing properties, protein denaturation rate, and roughness on hands of this body shampoo, the results were 〇, 〇, respectively.
It was ◎, ◎. Example 10 A shampoo having the following composition was prepared. Cocoyl methyl taurine-Na 4 Compound 4 8 Compound 8 8 Coconut fatty acid diethanolamide 5 Fragrance 0.3 Water Residual As a result of investigating the foaming properties, detergency, protein denaturation rate, and roughness of hands of this shampoo, the results were 〇, 〇, ◎, respectively. ◎
It was hot.
Claims (1)
リスチル基、パルミチル基、ステアリル基、イソ
ステアリル基またはオレイル基、M1はナトリウ
ム、カリウム、アンモニウムまたはトリエタノー
ルアンモニウムである。) で表わされる高級脂肪酸アミドスルホン酸塩と、 一般式(B) (上記式中で、R2はカプリル基、ラウリル基、
ミリスチル基、パルミチル基、ステアリル基また
はオレイル基、M2はナトリウム、カリウム、ア
ンモニウムまたはトリエタノールアンモニウムで
ある。) で表わされるN―(2―アルキル―2―ヒドロキ
シエチル)―N―メチルアミノエタノールリン酸
エステル塩とを有効成分として含有している低刺
激性洗浄剤組成物。 2 前記の一般式(A)で表わされる高級脂肪酸アミ
ドスルホン酸塩と一般式(B)で表わされるN―(2
―アルキル―2―ヒドロキシエチル)―N―メチ
ルアミノエタノールリン酸エステル塩との重量比
が3:1乃至1:20の範囲であり、そして(A)+(B)
の含有量が洗浄剤組成物全量中の10乃至50重量%
である特許請求の範囲第1項記載の低刺激性洗浄
剤組成物。[Claims] 1 General formula (A) (In the above formula, R 1 is a caprylic, lauryl, myristyl, palmityl, stearyl, isostearyl, or oleyl group, and M 1 is sodium, potassium, ammonium, or triethanolammonium.) Fatty acid amide sulfonate and general formula (B) (In the above formula, R 2 is a caprylic group, a lauryl group,
myristyl, palmityl, stearyl or oleyl group, M2 is sodium, potassium, ammonium or triethanolammonium. ) A hypoallergenic detergent composition containing N-(2-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester salt as an active ingredient. 2 Higher fatty acid amide sulfonate represented by the above general formula (A) and N-(2
-alkyl-2-hydroxyethyl)-N-methylaminoethanol phosphate ester salt, the weight ratio is in the range of 3:1 to 1:20, and (A) + (B)
The content of is 10 to 50% by weight in the total amount of the cleaning composition.
The hypoallergenic cleaning composition according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29560985A JPS62151497A (en) | 1985-12-26 | 1985-12-26 | Low irritant detergent composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29560985A JPS62151497A (en) | 1985-12-26 | 1985-12-26 | Low irritant detergent composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62151497A JPS62151497A (en) | 1987-07-06 |
JPH0226672B2 true JPH0226672B2 (en) | 1990-06-12 |
Family
ID=17822838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29560985A Granted JPS62151497A (en) | 1985-12-26 | 1985-12-26 | Low irritant detergent composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62151497A (en) |
-
1985
- 1985-12-26 JP JP29560985A patent/JPS62151497A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS62151497A (en) | 1987-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0542998B2 (en) | ||
JPS62295997A (en) | Low irritant detergent composition | |
JPH0625695A (en) | Detergent composition | |
JPH01186812A (en) | Detergent composition | |
JPS5942038B2 (en) | Hair shampoo - composition | |
JPH0548800B2 (en) | ||
JPH0226672B2 (en) | ||
JPS61272294A (en) | Detergent composition | |
JPS61272295A (en) | Detergent composition | |
JPS58138799A (en) | Detergent composition | |
JP2002317194A (en) | Detergent composition | |
JPH03109497A (en) | Detergent composition having low stimulating property | |
JPH06128587A (en) | Detergent composition | |
JPH0542999B2 (en) | ||
JPH03281700A (en) | Lowly irritating detergent composition | |
JPH03109498A (en) | Cleaning agent composition having low stimulating property | |
JP2955031B2 (en) | Hypoallergenic detergent composition | |
JPH0320213A (en) | Liquid detergent composition for body cleaning | |
JPH03124797A (en) | Detergent composition of low irritation | |
JPS5918440B2 (en) | cleaning composition | |
JPH03106999A (en) | Lowly irritant detergent composition | |
JPH03109496A (en) | Detergent composition having low stimulating property | |
JPH04243809A (en) | Cleaning agent composition having low irritation | |
JPH03131694A (en) | Low-irritant detergent composition | |
JPH03131693A (en) | Low-irritant detergent composition |